William H. Barr

2.3k total citations
60 papers, 1.7k citations indexed

About

William H. Barr is a scholar working on Pediatrics, Perinatology and Child Health, Pharmacology and Oncology. According to data from OpenAlex, William H. Barr has authored 60 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pediatrics, Perinatology and Child Health, 14 papers in Pharmacology and 12 papers in Oncology. Recurrent topics in William H. Barr's work include Pharmaceutical studies and practices (18 papers), Antibiotics Pharmacokinetics and Efficacy (11 papers) and Drug Solubulity and Delivery Systems (10 papers). William H. Barr is often cited by papers focused on Pharmaceutical studies and practices (18 papers), Antibiotics Pharmacokinetics and Efficacy (11 papers) and Drug Solubulity and Delivery Systems (10 papers). William H. Barr collaborates with scholars based in United States, Switzerland and Germany. William H. Barr's co-authors include Sidney Riegelman, H. Thomas Karnes, Vinod P. Shah, Leslie Z. Benet, Avraham Yacobi, Sunil S. Iyer, Jerome P. Skelly, Joseph Adir, Lorne K. Garrettson and Joseph R. Robinson and has published in prestigious journals such as Analytical Chemistry, Journal of Controlled Release and International Journal of Pharmaceutics.

In The Last Decade

William H. Barr

60 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
William H. Barr United States	24	422	341	309	282	274	60	1.7k
Henning Blume Germany	25	492 1.2×	249 0.7×	338 1.1×	168 0.6×	215 0.8×	89	2.1k
Hiroyasu Ogata Japan	24	383 0.9×	245 0.7×	259 0.8×	432 1.5×	182 0.7×	100	1.7k
Dale P. Conner United States	24	744 1.8×	594 1.7×	374 1.2×	262 0.9×	221 0.8×	56	2.7k
Mario L. Rocci United States	24	161 0.4×	322 0.9×	326 1.1×	256 0.9×	360 1.3×	73	2.1k
Oliver Yoa‐Pu Hu Taiwan	24	330 0.8×	138 0.4×	305 1.0×	195 0.7×	176 0.6×	86	1.7k
J. Robert Powell United States	27	130 0.3×	628 1.8×	233 0.8×	281 1.0×	358 1.3×	77	2.0k
K.C. Kwan United States	17	178 0.4×	175 0.5×	230 0.7×	270 1.0×	503 1.8×	33	1.5k
Shrikant V. Dighe United States	11	184 0.4×	177 0.5×	402 1.3×	210 0.7×	336 1.2×	20	1.7k
James T. Doluisio United States	21	315 0.7×	208 0.6×	261 0.8×	339 1.2×	345 1.3×	53	1.4k
K. C. Yeh United States	23	126 0.3×	161 0.5×	227 0.7×	187 0.7×	297 1.1×	51	1.6k

Countries citing papers authored by William H. Barr

Since Specialization

Citations

This map shows the geographic impact of William H. Barr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William H. Barr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William H. Barr more than expected).

Fields of papers citing papers by William H. Barr

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William H. Barr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William H. Barr. The network helps show where William H. Barr may publish in the future.

Co-authorship network of co-authors of William H. Barr

This figure shows the co-authorship network connecting the top 25 collaborators of William H. Barr. A scholar is included among the top collaborators of William H. Barr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William H. Barr. William H. Barr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Barr, William H., et al.. (2012). A biorelevant in vitro release/permeation system for oral transmucosal dosage forms. International Journal of Pharmaceutics. 430(1-2). 104–113. 16 indexed citations

Davies, Bruce, V. Ramakrishnan, H. Thomas Karnes, et al.. (2011). Evaluation of the Effect of Ammonia on Nicotine Pharmacokinetics Using Rapid Arterial Sampling. Nicotine & Tobacco Research. 14(5). 586–595. 6 indexed citations

Davies, Bruce, William M. Adams, W. S. Lewis, et al.. (2010). Rapid automated blood sampling system for pharmacokinetics studies of cigarette smoking. Nicotine & Tobacco Research. 12(4). 319–325. 3 indexed citations

Garnett, William R., et al.. (2010). Diazepam autoinjector intramuscular delivery system versus diazepam rectal gel: A pharmacokinetic comparison. Epilepsy Research. 93(1). 11–16. 27 indexed citations

Iyer, Sunil S., et al.. (2007). A ‘biorelevant’ system to investigate in vitro drug released from a naltrexone implant. International Journal of Pharmaceutics. 340(1-2). 104–118. 23 indexed citations

Iyer, Sunil S., William H. Barr, & H. Thomas Karnes. (2006). Characterization of a potential medium for ‘biorelevant’ in vitro release testing of a naltrexone implant, employing a validated stability-indicating HPLC method. Journal of Pharmaceutical and Biomedical Analysis. 43(3). 845–853. 19 indexed citations

Iyer, Sunil S., William H. Barr, & H. Thomas Karnes. (2006). Profiling in vitro drug release from subcutaneous implants: a review of current status and potential implications on drug product development. Biopharmaceutics & Drug Disposition. 27(4). 157–170. 51 indexed citations

Menon, Rajeev & William H. Barr. (2003). Comparison of ceftibuten transport across Caco‐2 cells and rat jejunum mounted on modified ussing chambers. Biopharmaceutics & Drug Disposition. 24(7). 299–308. 20 indexed citations

Wu‐Pong, Susanna, et al.. (1999). Oligonucleotide transport in rat and human intestine Ussing chamber models. Biopharmaceutics & Drug Disposition. 20(9). 411–416. 13 indexed citations

10.

Barr, William H.. (1999). Cyclosporine: the case for expanding bioequivalence criteria to include measures of individual bioequivalence in relevant population subsets. Transplantation Proceedings. 31(3). 25S–30S. 9 indexed citations

11.

Barr, William H.. (1999). Scientific and professional concerns regarding product interchange and subsequent monitoring of cyclosporine and other critical dose drugs. Transplantation Proceedings. 31(3). 1645–1648. 4 indexed citations

12.

Buch, Akshay & William H. Barr. (1998). Absorption of propranolol in humans following oral, jejunal, and ileal administration.. Pharmaceutical Research. 15(6). 953–957. 11 indexed citations

13.

Slattum, Patricia W., Jürgen Venitz, & William H. Barr. (1996). Comparison of Methods for the Assessment of Central Nervous System Stimulant Response after Dextroamphetamine Administration to Healthy Male Volunteers. The Journal of Clinical Pharmacology. 36(11). 1039–1050. 20 indexed citations

14.

Barr, William H., et al.. (1995). Pharmacokinetics of ceftibuten in children. The Pediatric Infectious Disease Journal. 14(Supplement). S93–101. 20 indexed citations

15.

Peck, Carl C., William H. Barr, Leslie Z. Benet, et al.. (1994). Opportunities for Integration of Pharmacokinetics, Pharmacodynamics, and Toxicokinetics in Rational Drug Development. The Journal of Clinical Pharmacology. 34(2). 111–119. 37 indexed citations

16.

Charman, William N., et al.. (1993). Absorption of Danazol After Administration to Different Sites of the Gastrointestinal Tract and the Relationship to Single‐ and Double‐Peak Phenomena in the Plasma Profiles. The Journal of Clinical Pharmacology. 33(12). 1207–1213. 45 indexed citations

17.

Peck, Carl C., William H. Barr, Leslie Z. Benet, et al.. (1992). Opportunities for Integration of Pharmacokinetics, Pharmacodynamics, and Toxicokinetics in Rational Drug Development. Journal of Pharmaceutical Sciences. 81(6). 605–610. 49 indexed citations

18.

Peck, Carl C., William H. Barr, Leslie Z. Benet, et al.. (1992). Opportunities for integration of pharmacokinetics, pharmacodynamics, and toxicokinetics in rational drug development. Clinical Pharmacology & Therapeutics. 51(4). 465–473. 141 indexed citations

19.

Barr, William H., Chin‐Chung Lin, Elaine Radwanski, et al.. (1991). The pharmacokinetics of ceftibuten in humans. Diagnostic Microbiology and Infectious Disease. 14(1). 93–100. 44 indexed citations

20.

Amidon, Gordon L., William H. Barr, Leslie Z. Benet, et al.. (1990). Report of the Workshop on In Vitro and In Vivo Testing and Correlation for Oral Controlled/Modified-Release Dosage Forms. Journal of Pharmaceutical Sciences. 79(9). 849–854. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact